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[Argininelvasopressin (AVP) stimulates maximal prostaglandin E2 production in
cultured rat renal mesangial cells within 2min. As early as 10s after addition ofAVP
(I10-6M) a significant loss of radioactivity from phosphatidylinositol 4,5-bisphosphate
but not from phosphatidylinositol 4-phosphate and phosphatidylinositol was
observed in cells prelabelled with 32P;. Cells labelled with ['4C]arachidonic acid
showed an increase of label in 1,2-diacylglycerol after 15s and in phosphatidic acid
after 30s upon stimulation with AVP. Pretreatment of the cells with indomethacin
(10-5M) did not abolish the effect of AVP on the increased labelling of phosphatidic
acid.
AVP is known to exert at least two major effects
on the kidney. It enhances the reabsorption of
water in the distal convolute and collecting tubule
and has furthermore been shown to reduce the
glomerular ultrafiltration coefficient, Kf (Ichikawa
& Brenner, 1977; Schor et al., 1981). This latter
effect is thought to be caused by a contraction of
mesangial cells (Mahieu et al., 1980; Ausiello et al.,
1980; Scharschmidt & Dunn, 1983). AVP has also
been shown to induce PGE2 synthesis, the major
cyclo-oxygenase product of cultured mesangial
cells (Kreisberg et al., 1982; Scharschmidt &
Dunn, 1983). This increase in prostaglandin
production is thought to modulate the contractile
effect of AVP on mesangial cells (Kreisberg et al.,
1982).
In view of these connections experiments were
designed to gather information on the mechanism
by which AVP induces PG synthesis in mesangial
cells. It is known that the rate-limiting step of PG
synthesis is the availability of the cyclo-oxygenase
substrate arachidonic acid (Isakson et al., 1978).
One of the mechanisms for arachidonic acid
release is the activation of the so-called phosphati-
dylinositol cycle which leads to the liberation of
Abbreviations used: AVP, [arginine]vasopressin; PG,
prostaglandin; PI, PIP, PIP2, phosphatidylinositol and
its 4-phosphate and 4,5-bisphosphate; PA, phosphatidic
acid; DG, diacylglycerol.
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arachidonic acid from phospholipids (Bell et al.,
1979; Marshall et al., 1980, 1981; Lapetina, 1982).
Since it has been demonstrated that AVP activates
this cycle in hepatocytes (Billah & Michell, 1979;
Kirk & Michell, 1981; Michell et al., 1981; Litosch
et al., 1983; Thomas et al., 1983) we determined
whether or not AVP induces PG synthesis in
cultured mesangial cells by a stimulation of the
phosphatidylinositol cycle.
Experimental
Materials
Lipid standards, AVP and indomethacin were
obtained from Sigma. T.l.c. plates (pre-coated
silica gel 60 with concentration zone, 0.25mm
thick) were from Merck, Darmstadt, Germany. [1-
14C]Arachidonic acid and carrier-free 32p, were
purchased from Amersham International. All
other chemicals for t.l.c. were from Merck.
Cell culture
Cultivation of rat mesangial cells was done as
described (Kurtz et al., 1982). For all experiments
the first passage of mesangial cell cultures was
used. The cells were grown in RPMI 1640 (Boeh-
ringer, Mannheim, Germany) supplemented with
10% foetal calf serum (Boehringer), penicillin (100
units/ml), streptomycin (100.ug/ml) (Boehringer)
and bovine insulin at 0.66 unit/ml (Sigma). Tissue
dishes (7cm2; Greiner, Niirtingen, Germany) were
incubated at 37°C in a humidified atmosphere in
incubators under CO2/02/N2 (1:4 :15).
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Cell labelling
Medium was removed and the cells were
incubated in MEM (Boehringer) supplemented
with fatty acid-free bovine serum albumin
(0.3mg/ml) (Sigma) and [14C]arachidonic acid
(0.25 uCi/ml) for 24h. For the determination of
polyphosphoinositides, cells were labelled with
carrier-free 32P, (lOOpCi/ml) in phosphate-poor
MEM (SOMm-Pi) for 24h. After this prelabelling
period the medium was replaced by fresh medium
either with or without (control) AVP (10-6 M).
Incubations were terminated by a rapid with-
drawal of the incubation medium and the addition
of 1 ml of ice-cold methanol. The aspirated
medium was frozen in liquid N2 and stored at
- 60°C until use. Indomethacin (Sigma) was added
where indicated at a final concentration of 10-5M
15 min before addition of agonists.
Extraction
The lipid extraction was done according to Bligh
& Dyer (1959) with a final proportion of 2ml of
methanol, 2ml of chloroform and 1.6ml of water
(containing 0.74% KCl, 0.04% CaCl2 and 0.034%
MgCl2). After removal of the first chloroform
extract, the remaining methanol/water phase was
acidified with HCl (final concentration 0.01 M) and
extracted twice with 2ml of chloroform. The
extraction of polyphosphoinositides was done at
acid pH in all three steps. The chloroform extracts
were combined and dried in a rotation evaporator,
dissolved in 200ul of chloroform/methanol (2:1,
v/v) and an aliquot was taken for t.l.c.
Chromatography
For separation of phospholipids, chromato-
graphs were developed in one dimension
using chloroform/methanol/acetic acid/water
(100:30:35:3, by vol.). This solvent system
allowed the complete separation of sphingomyelin,
phosphatidylcholine, phosphatidylinositol, phos-
phatidylserine, phosphatidylethanolamine, phos-
phatidic acid and cardiolipin (Thomas & William-
son, 1983). For separation of neutral lipids,
chromatographs were developed in one dimen-
sion using n-heptane/diethyl ether/acetic acid
(75:25:4, by vol.). This solvent system allowed the
complete separation of free fatty acid, monoacyl-
glycerol, 1,2-diacylglycerol, 1,3-diacylglycerol, tri-
acylglycerol and cholesteryl ester (Korte & Casey,
1982). Polyphosphoinositides were separated on
thin layer plates pretreated with 1% potassium
oxalate containing 2mM-EDTA using chloroform/
methanol/4M-NH4OH (9:7:2, by vol.) (Billah &
Lapetina, 1982). For phospholipid separation
standards of PA, PI, phosphatidylcholine, phos-
phatidylethanolamine and phosphatidylserine
were added as carriers; for neutral lipid separation
standards of triacylglycerol, cholesterol ester, 1,2-
DG and 1,3-DG and for polyphosphoinositides
separation standards of PIP2 and PIP were added
as carriers. The lipids were visualized by iodine
staining and 32P-labelled lipids additionally by
autoradiography.
Analyses of radiochromatograms
The developed t.l.c. plates were analysed with a
TLC-Linear-Analyzer LB 2820 from Berthold,
Miinchen, Germany. The detection efficiency for
14C was about 10%. 32P-labelled lipids were
scraped off and counted by liquid scintillation in
water (Cerenkov counting).
PG and protein analysis
PGE2 concentrations of the culture mediums
were determined by radioimmunoassay for PGE2
(New England Nuclear). Protein determination
was done according to the method of Lowry et al.
(1951) with bovine serum albumin (Sigma) as
standard.
Results
Effect of A VP on PGE2 synthesis in rat mesangial
cells
The time-dependence of basal and AVP-stimu-
lated synthesis of PGE2 by mesangial cells is
shown in Fig. 1. Stimulation of PGE2 synthesis by
10-6M-AVP was found to occur rapidly; 64% and
93% of the total amount of PGE2 present after
10min were already produced 30s and 120s
respectively after AVP stimulation. The stimula-
tion of PGE2 synthesis was therefore essentially
complete within 2min. PGE2 synthesis was also
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Fig. 1. Time dependence ofPGE2 production by cultured
mesangial cells incubated in MEM without or with A VP
(10-6 M)
Data are expressed as ng of PGE2 produced per mg
of cell protein with (0) or without (0) AVP. Values
are mean +S.E.M., n = 5.
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found to be stimulated in the control experiments
but to a much lesser degree than in those with
AVP. The net rate of production during the first
2min after stimulation with AVP was 8.4ng of
tPGE2/min per mg of protein (control 2.9ng/min
per mg) and then returned to a basal level of about
0.15ng/min per mg.
Effect ofA VP on phospholipase C in rat mesangial
cells
Addition ofAVP (10-6 M) to cultured mesangial
cells prelabelled with [14C]arachidonic acid stimu-
lated the rapid and transient formation of [14C]1,2-
DG and [14C]PA (Figs. 2 and 3). Maximal
formation of 1 ,2-DG occurred as early as 15 s after
addition of AVP (182% of control value) and
returned to control values after 10min. Phosphati-
dic acid levels had a maximum (174% of control
value) 30s after addition of AVP and then reached
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Fig. 2. Time course of [14C]arachidonic acid radioactivity
in 1,2-DG in mesangial cells stimulated with A VP (1O-6M)
*, Control (no agonist); 0, AVP (luM). Values are
mean +S.E.M., n = 5.
a plateau. After 5min PA levels slowly decreased
and reached near-control values after 10min.
Although a small initial decrease in PI was
observed during the first 15s (results not shown),
this decrease was not statistically significant. As
shown in Fig. 4, AVP treatment provoked a rapid
decrease in the level of 32p found in PIP2. This
effect was maximal within lOs (70% of control),
the earliest time interval examined. At 1 min after
the addition of AVP the level of 32p in PIP2
increased and, approached control level, followed
by an increase above initial levels after 2min. PIP
was also found to decrease initially. This decrease,
however, was not statistically significant and PIP
levels rapidly increased above the initial values. It
should be noted in this connexion that no
significant change of radioactivity was observed in
phosphatidylcholine, phosphatidylethanolamine
or phosphatidylserine in AVP-stimulated cells.
AVP-induced stimulation of the PI cycle was not
prevented by indomethacin
To examine whether the PI cycle was directly
stimulated by AVP or only indirectly stimulated by
cyclo-oxygenase products we determined the time
course of PA in the presence of arachidonic acid
(10-5 M), arachidonic acid (10-5M) plus indometha-
cin (lO-5M) and AVP (10-6M) plus indomethacin
(l0-5 M).
Fig. 5 shows that addition of arachidonic acid to
cultured mesangial cells led to an increase of the
32p level in PA. This increase in PA was abolished
by the addition of indomethacin. Simultaneous
addition ofAVP and the cyclo-oxygenase inhibitor
indomethacin, however, did not prevent the AVP-
stimulated increase in PA.
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Fig. 3. Time course of [14CIarachidonic acid radioactivity
in PA in mesangial cells stimulated with A VP (10-6M)
*, Control (no agonist); 0, AVP (1 pM). Values are
mean±+ S.E.M., n = 5.
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Fig. 4. Time course of 32P radioactivity in
polyphosphoinositides
Open symbols represent stimulation with AVP
(10-6M); filled symbols represent control values. 0,
0, PIP2; O, *, PIP. Values are mean+S.E.M.,
n = 5.
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Fig. 5. Effect ofindomethacin on 32P radioactivity in PA in
presence ofA VP and arachidonic acid
32P radioactivity in PA was determined 30s after
addition of AVP or arachidonic acid (AA) alone or
together with indomethacin (Indo.). Values are
mean +S.E.M., n = 5.
Discussion
The results presented in this paper are compati-
ble with the hypothesis that AVP-stimulated PG
synthesis is linked to an increased turnover of
polyphosphoinositides in cultured rat mesangial
cells. Since it is known that the rate limiting step in
PG synthesis is the availability of free arachidonic
acid as substrate for cyclo-oxygenase, AVP must
cause the release of arachidonic acid from certain
phospholipids. The bulk of arachidonic acid in
mammalian cells is bound to the fatty acyl chains
of glycerophospholipids, almost exclusively in the
2-acyl position (for review see Irvine, 1982).
There are two possible mechanisms by which
arachidonic acid may be released from phospho-
lipids: one is the action of a phospholipase A2
(Lapetina, 1982) and the other is the combined
action of a phospholipase C and DG lipase (Mauco
et al., 1978; Bell et al., 1979). From the present data
it is clear that AVP causes rapid hydrolysis of PIP2
in cultured rat mesangial cells. This response is
quite similar to that observed during AVP action
in cultured rat hepatocytes (Thomas et al., 1983).
It seems most likely that the decrease in 32p label
in PIP2 is due to the activation of a specific
phospholipase C. An alternative explanation for
the decrease of 32p labelling in PIP2 would be the
decreased synthesis of PIP2 or the increased
conversion ofPIP2 to PIP and PI viaphosphomono-
esterases. However, these are unlikely explana-
tions as labelling of neither PIP nor PI (results not
shown) increased during this early time period.
The conclusion that phospholipase C activity is
increased is corroborated by the findings of several
authors who have demonstrated a selective break-
down of PIP2 in various tissues (for review see
Berridge, 1984). This early decrease in PIP2 was
accompanied by the rapid and transient formation
of [14C]1,2-DG and [14C]PA (Figs. 2 and 3).
Maximal formation of 1,2-DG preceded that of
PA, indicating the sequential action of a specific
phospholipase C and 1,2-DG kinase.
This result clearly shows that AVP stimulates the
PI cycle in cultured renal mesangial cells. Since an
activation of the PI-cycle provides possibilities for
arachidonic acid release (Bell et al., 1979; Lape-
tina, 1982) and the availability of arachidonic acid
is the rate-limiting step in PG synthesis, our results
provide evidence that AVP enhances PG synthesis
by an activation of the PI cycle. Conceivably, the
PI cycle could also be activated by cyclo-oxygenase
products, as demonstrated in platelets (Siess et al.,
1983). However, this possibility can be excluded
because indomethacin inhibited the stimulatory
effect on the PI cycle of exogenous addition of
arachidonic acid, but not the stimulation seen with
AVP (Fig. 5). Our results furthermore suggest that
any arachidonate liberated in response to AVP is
either insufficient in quantity, or is in the wrong
place to stimulate additionally phospholipase C.
The kinetics of the formation of 1,2-DG and PA
on one hand, and of PGE2 on the other (Fig. 1),
are also in harmony with the hypothesis that an
activation of the PI cycle liberates arachidonic acid
from phospholipids. Three possibilities need to be
considered in this regard: (a) increased availability
of the substrate 1,2-DG to the DG lipase, (b)
activation of the Ca2+-stimulated phospholipase
A2 by PA, which acts as Ca2+-ionophore (Putney et
al., 1980; Salmon & Honeyman, 1980; Holmes &
Yoss, 1983), and (c) the release of arachidonic acid
by a PA-specific phospholipase A2 (Billah et al.,
1981). We are currently investigating which of
these three mechanisms operates in AVP-stimulat-
ed renal mesangial cells.
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